Fc fragment News and Research

RSS
Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

The neutralization potential of nanobodies against SARS-CoV-2

The neutralization potential of nanobodies against SARS-CoV-2

Multivalent antibodies show high potency against SARS-CoV-2 in new study

Multivalent antibodies show high potency against SARS-CoV-2 in new study

The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants

The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Wyss Institute researchers develop new capture technology for cancer diagnostics

Wyss Institute researchers develop new capture technology for cancer diagnostics

Choroidal consequences differ between anti-VEGF therapies

Choroidal consequences differ between anti-VEGF therapies

Virdante Pharmaceuticals receives US key patent for Sialic Switch technology

Virdante Pharmaceuticals receives US key patent for Sialic Switch technology